SGHERZA N, CURCI P, STRAFELLA V, RIZZI R, MUSTO P. Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma. Acta Biomed. 2021;92(2):e2021205. doi:10.23750/abm.v92i2.11395